NephroGenex To Participate In Two Healthcare Conferences In June

RALEIGH, N.C.--(BUSINESS WIRE)--NephroGenex, Inc. (Nasdaq: NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today announced that Chief Executive Officer Pierre Legault will present a corporate overview of the Company and meet with members of the investment community at two healthcare conferences in June.

Help employers find you! Check out all the jobs and post your resume.